Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Long-term improvement in BPH patients given NX-1207

March 23, 2007

Novel agents are reported for use in the treatment of genitourinary disorders

March 22, 2007

IND for second siRNA therapeutic based on SR Pharma chemistry

March 21, 2007

Alkaline phosphatase shows benefit for patients with acute renal failure

March 19, 2007

Recent Bayer patents report novel therapeutic agents for urological disorders

March 8, 2007

Gruenenthal licenses urinary incontinence product to KeyNeurotek

March 6, 2007

NX-1207 completes long-term follow-up study in BPH

March 5, 2007

Vaprisol approved for treatment of hypervolemic hyponatremia

March 2, 2007

Plethora plans phase III program for Invicorp in erectile dysfunction

Feb. 28, 2007

New treatment option for urological disorders reported by Takeda

Feb. 28, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...